Delivery Order SPE2DB20D3103-SPE2DB24FP0P1
Award Date
6/4/24
Potential Completion Date
6/5/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,566,066,543 units of the pharmaceutical product Otezla 30 mg tablets. The $69,856.77 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 10, 2024. The award is a Delivery Order placed under DLA's Indefinite Delivery Contract, which has a total potential value of up to $999,999,999 for delivering a range of medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of OTEZLA 30 mg tablets to the Defense Logistics Agency (DLA). The $3,182.12 firm fixed-price delivery order has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor AmerisourceBergen Corporation, provides for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,545.79 firm fixed price delivery order has a completion date of March 25, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564401359 OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,213.60 and is a firm fixed price delivery order, with an ultimate completion date of April 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,656.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Otezla 30 mg tablets. The contract has a performance period through January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OTEZLA 30 mg tablets in 60-count packages to the U.S. government. The contract has a ceiling value of $22,266.98 and an ultimate completion date of May 7, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency responsible for providing logistics and acquisition support for medical commodities to the U.S. Armed Forces and...
This federal contract award is for the delivery of Otezla 30mg tablets to the Defense Logistics Agency (DLA). The awardee is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through their Corporate Office division. The contract has a ceiling value of $5,795.14 and a completion date of June 13, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OTEZLA 30 MG TABLET 60S, a prescription medication, to the Defense Logistics Agency (DLA). The $21,737.54 firm fixed-price delivery order has an ultimate completion date of April 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 30 mg Otezla tablets. The contract has a potential value of $3,397.17 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,341.67 firm fixed-price delivery order is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of April 25, 2024 and was awarded on April 24, 2024. This award is a child contract under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...